1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
64FED5A0189E6EB0385256C63005B5C03
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/positioning-and-pricing-for-brand-success?opendocument
18
19opendocument
203.226.254.115
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Brand Management and Product Leadership Branding and Identity

Positioning and Pricing for Brand Success

DB Image

ID: 4305


Features:

Graphics


Words: 5,215


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
STUDY OVERVIEW


This 16-page document, geared to pharmaceutical marketing and brand team executives, examines how best practice companies make trademark and branding decisions about pricing, positioning and promotion. The pros and cons of these activities as they related to single, dual and hybrid brand approaches are discussed. For example, best practices include: 'Employ a hybrid brand and blended positioning to leverage limited marketing resources and budget,' and 'Develop bundled product strategies to managed care organizations to provide beneficial molecule-group reimbursement options.

KEY TOPICS

Positioning for power and marketplace success
Pricing: a key to value optimization
Promotion and launch management
Labeling and packaging


SAMPLE KEY FINDINGS

Develop bundled product strategies to allow MCOs to provide beneficial moleculegroup reimbursement options.

Pharmaceutical companies can drive revenue for products with multiple trademarks by offering bundled pricing rates to managed care organizations. Often, by developing bundle strategies, one brand’s success can carry the remaining trademarks.

Industries Profiled:
Pharmaceutical; Biotech; Health Care


Companies Profiled:
AstraZeneca; Bristol-Myers Squibb; Pfizer; Sanofi-aventis; Novartis; Merck; GSK

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.